HIV Drug Assistance Program (HDAP)

**PLEASE NOTE: For all COVID-19 updates regarding this program please visit https://crine.org/covid-19**

The Massachusetts HIV Drug Assistance Program (HDAP) helps state residents who cannot afford to pay the full cost of the HIV-related drugs and health insurance they need.

ABOUT HDAP
HDAP is a program of the Office of HIV/AIDS within the Massachusetts Department of Public Health, funded through federal and state sources, including the U.S. Public Health Service/Health Resources and Services Administration and the Boston Public Health Commission AIDS Program through Part A of the Ryan White CARE Act.

HDAP is administered by Community Research Initiative and is among the nation’s most complete drug assistance programs for people living with HIV. It plays a crucial role in providing resources to a diverse population that may otherwise lack access to HIV-related medications and/or health insurance. More than half of HDAP enrollees are from communities of color, and approximately three-quarters of HDAP clients have incomes of less than 200 percent of the federal poverty level ($12,880).

HDAP can pay for:
•    medications and drug copays
•    private non-group health insurance premiums and drug copays
•    HIV-resistance testing (genotype and virtual phenotype lab tests)
•    post-exposure prophylaxis (PEP) for potential non-occupational exposure to HIV

For an overview of the HDAP/CHII programs, including eligibility requirements, please click here. More information is also available in our brochures:

Have you been exposed to HIV through a non-work-related event? Click here to learn about receiving antiretroviral treatment through HDAP’s Non-Occupational Post-Exposure Prophylaxis (nPEP) service.

Are you interested in preventing HIV by taking a once-daily pill? Click here to learn about PrEP and HDAP's PrEP Drug Assistance Program.